Physician profile
Jonathan A Mcbride
NPI 1962899526
$11,715.16
in general payments reported to CMS, 2019-2025
22 companies · $72.50 in 2025
The $72.50 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $224 · 2021: $487 · 2022: $309 · 2023: $439 · 2024: $166 · 2025: $72.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,420.52 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $588.73 | 2020-2024 | Senza |
| Relievant Medsystems, INC. | $155.12 | 2022-2023 | Intracept |
| Nalu Medical, INC. | $85.87 | 2021-2022 | |
| Medtronic, INC. | $63.69 | 2021 | |
| Innovation Technologies INC | $58.07 | 2021 | |
| Scilex Pharmaceuticals INC. | $46.16 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $28.68 | 2024 | Dupixent |
| Abbott Laboratories | $28.06 | 2025 | Proclaim, Eterna |
| Trevena, INC. | $27.86 | 2021 | |
| Alnylam Pharmaceuticals INC. | $24.29 | 2024 | Givlaari |
| Stimwave Technologies Incorporated | $22.26 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $20.09 | 2023 | Dysport |
| Abbvie INC. | $19.93 | 2024 | |
| Avanir Pharmaceuticals, INC. | $18.96 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stratus Medical, LLC | $17.96 | 2021 | |
| Grt US Holding, INC. | $17.74 | 2022 | |
| Stryker Corporation | $16.34 | 2025 | Mild Device Kit |
| Pacira Pharmaceuticals Incorporated | $14.29 | 2020 | |
| Ucb, INC. | $13.69 | 2024 | Bimzelx |
| Kyowa Kirin, INC. | $13.61 | 2025 | |
| Horizon Therapeutics Plc | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.